IBDEI06Z ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6881,2)
 ;;=^5009113
 ;;^UTILITY(U,$J,358.3,6882,0)
 ;;=L21.8^^42^487^262
 ;;^UTILITY(U,$J,358.3,6882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6882,1,3,0)
 ;;=3^Seborrheic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,6882,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,6882,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,6883,0)
 ;;=L21.9^^42^487^263
 ;;^UTILITY(U,$J,358.3,6883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6883,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,6883,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,6883,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,6884,0)
 ;;=L23.7^^42^487^30
 ;;^UTILITY(U,$J,358.3,6884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6884,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,6884,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,6884,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,6885,0)
 ;;=L23.9^^42^487^31
 ;;^UTILITY(U,$J,358.3,6885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6885,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,6885,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,6885,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,6886,0)
 ;;=L24.9^^42^487^163
 ;;^UTILITY(U,$J,358.3,6886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6886,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,6886,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,6886,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,6887,0)
 ;;=L25.9^^42^487^115
 ;;^UTILITY(U,$J,358.3,6887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6887,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,6887,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,6887,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,6888,0)
 ;;=L26.^^42^487^148
 ;;^UTILITY(U,$J,358.3,6888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6888,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,6888,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,6888,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,6889,0)
 ;;=L27.0^^42^487^265
 ;;^UTILITY(U,$J,358.3,6889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6889,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,6889,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,6889,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,6890,0)
 ;;=L27.1^^42^487^266
 ;;^UTILITY(U,$J,358.3,6890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6890,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,6890,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,6890,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,6891,0)
 ;;=L29.0^^42^487^250
 ;;^UTILITY(U,$J,358.3,6891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6891,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,6891,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,6891,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,6892,0)
 ;;=L29.9^^42^487^251
 ;;^UTILITY(U,$J,358.3,6892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6892,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,6892,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,6892,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,6893,0)
 ;;=L30.0^^42^487^232
 ;;^UTILITY(U,$J,358.3,6893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6893,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,6893,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,6893,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,6894,0)
 ;;=L30.1^^42^487^140
 ;;^UTILITY(U,$J,358.3,6894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6894,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,6894,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,6894,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,6895,0)
 ;;=L30.2^^42^487^132
 ;;^UTILITY(U,$J,358.3,6895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6895,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,6895,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,6895,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,6896,0)
 ;;=L30.4^^42^487^144
 ;;^UTILITY(U,$J,358.3,6896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6896,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,6896,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,6896,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,6897,0)
 ;;=L30.8^^42^487^135
 ;;^UTILITY(U,$J,358.3,6897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6897,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,6897,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,6897,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,6898,0)
 ;;=L30.9^^42^487^136
 ;;^UTILITY(U,$J,358.3,6898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6898,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,6898,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,6898,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,6899,0)
 ;;=L40.0^^42^487^253
 ;;^UTILITY(U,$J,358.3,6899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6899,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,6899,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,6899,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,6900,0)
 ;;=L40.1^^42^487^256
 ;;^UTILITY(U,$J,358.3,6900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6900,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,6900,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,6900,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,6901,0)
 ;;=L40.2^^42^487^11
 ;;^UTILITY(U,$J,358.3,6901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6901,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,6901,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,6901,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,6902,0)
 ;;=L40.3^^42^487^255
 ;;^UTILITY(U,$J,358.3,6902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6902,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,6902,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,6902,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,6903,0)
 ;;=L40.4^^42^487^157
 ;;^UTILITY(U,$J,358.3,6903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6903,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,6903,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,6903,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,6904,0)
 ;;=L40.8^^42^487^252
 ;;^UTILITY(U,$J,358.3,6904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6904,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,6904,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,6904,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,6905,0)
 ;;=L40.9^^42^487^254
 ;;^UTILITY(U,$J,358.3,6905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6905,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,6905,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,6905,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,6906,0)
 ;;=L50.9^^42^487^286
 ;;^UTILITY(U,$J,358.3,6906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6906,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,6906,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,6906,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,6907,0)
 ;;=L53.8^^42^487^147
 ;;^UTILITY(U,$J,358.3,6907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6907,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,6907,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,6907,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,6908,0)
 ;;=L53.9^^42^487^146
 ;;^UTILITY(U,$J,358.3,6908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6908,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,6908,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,6908,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,6909,0)
 ;;=L54.^^42^487^145
 ;;^UTILITY(U,$J,358.3,6909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6909,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,6909,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,6909,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,6910,0)
 ;;=L56.0^^42^487^139
 ;;^UTILITY(U,$J,358.3,6910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6910,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,6910,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,6910,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,6911,0)
 ;;=L56.1^^42^487^138
 ;;^UTILITY(U,$J,358.3,6911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6911,1,3,0)
 ;;=3^Drug Photoallergic Response
